Henkel has launched a class of 3D printing resins for health care applications under its leading Loctite brand. The broad portfolio of high-performance photopolymers offers a range of biocompatibility standards from safe to touch parts to medical devices. In addition to the established portfolio of Loctite 3D printing resins, the company innovates to deliver tailored formulations to fit the specific application requirements and market demands for optimized production. Recently, the Henkel 3D printing facilities in Concord (laboratory) and Dixon (production) in California have achieved the ISO 13485:2016 certification for medical applications. Henkel 3D printing resins are designed and manufactured in accordance with ISO 13485 quality management standards to ensure uniformity in design, development, production and delivery of medical devices. In Henkel’s case specifically, it covers the design and manufacturing of biocompatible resins and other materials used to produce non-implantable medical devices.
For more information, visit LoctiteAM.com.
